ArticlePharmaceuticals (Basel, Switzerland)2023

In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation.

Muhammad Hamid Siddique et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.